Literature DB >> 20661364

Six hours positive pressure ventilation with size 5 laryngeal mask in a 55-kg patient.

Jayashree Patki1, C Naresh K Reddy.   

Abstract

Entities:  

Year:  2010        PMID: 20661364      PMCID: PMC2900752          DOI: 10.4103/0019-5049.63631

Source DB:  PubMed          Journal:  Indian J Anaesth        ISSN: 0019-5049


× No keyword cloud information.
Sir, I read the letter written by Dr. Jayashree Sood in relation to an article by Dr. Kerem (6 hrs. Positive pressure ventilation with size 5 LMA). I would like to share my experience of using LMA (laryngeal mask airway) for a prolonged period, but in a spontaneously breathing patient. One ASA grade1 (wt. 60 kg) patient was posted for cosmetic surgery. General anaesthesia was planned and size 4 LMA was inserted under the effect of inj. propofol (120 mg), inj. fentanyl (150 μg) and inj. midazolam (2 mg) thinking that it is a small procedure, because of some mis-communication between the surgeon and the anaesthetist. Then, we realized that it would take a much longer time. But still we decided to continue the procedure, instead of opting for intubation and controlled ventilation. The entire procedure lasted for 15 h. During this time, anaesthesia was maintained with O2:N2O (1 + 1l), sevoflurane (1–1.5%), propofol infusion 6 ml/h (1mg/kg/h), inj. fentanyl 25 μg/h (0.5–1 μg/kg/h), inj. midazolam (1 mg/2h) on Datex Ohmeda Aespire anaesthesia station with circle absorber. Last dose of midazolam and fentanyl was given 1 h before the end of the surgery. Propofol infusion was stopped 30 min before, sevoflurane 20 min before and N2 O 10 min before removing the LMA. We noticed that patient was very much awake, alert and oriented without any intraoperative awareness while shifting out of OT. There were no signs of delayed recovery. The patient was discharged on the next day. There were no neurovascular or airway complications[12] as described in the literature. LMA cuff was intact after 15 h of continuous use. Propofol and midazolam are known to alter the levels of lipids, especially triglycerides and cholesterol. In the propofol group, Ilhan et al. observed a significant increase in triglycerides and very low-density lipoprotein levels 4 h postoperatively. In the midazolam group, they observed a significant decrease in low-density lipoprotein, cholesterol at the end of and 4 and 24 h postoperatively.[3] Sevoflurane is known for causing hepatic dysfunction and its nephrotoxicity. So, serum creatinine, liver function tests and lipid profile were repeated on first and third postoperative days. They were found to be within normal limits, as demonstrated by Myles[4] that a propofol infusion technique does not result in elevation of serum lipids and supports its increased popularity in the maintenance of anaesthesia.
  4 in total

1.  Re-evaluation of appropriate size of the laryngeal mask airway.

Authors:  T Asai; K Murao; H Yukawa; K Shingu
Journal:  Br J Anaesth       Date:  1999-09       Impact factor: 9.166

2.  Effects of propofol and midazolam on lipids, glucose, and plasma osmolality during and in the early postoperative period following coronary artery bypass graft surgery: a randomized trial.

Authors:  Ilhan Oztekin; Sümeyye Gökdoğan; Deniz S Oztekin; Halim Işsever; Onur Göksel; Sevim Canik
Journal:  Yakugaku Zasshi       Date:  2007-01       Impact factor: 0.302

3.  Pharyngolaryngeal morbidity with the laryngeal mask airway in spontaneously breathing patients: does size matter?

Authors:  D M Grady; F McHardy; J Wong; F Jin; D Tong; F Chung
Journal:  Anesthesiology       Date:  2001-05       Impact factor: 7.892

4.  Serum lipid and glucose concentrations with a propofol infusion for cardiac surgery.

Authors:  P S Myles; M R Buckland; D J Morgan; A M Weeks
Journal:  J Cardiothorac Vasc Anesth       Date:  1995-08       Impact factor: 2.628

  4 in total
  1 in total

1.  A novel combination of the Arndt endobronchial blocker and the laryngeal mask airway ProSeal™ provides one-lung ventilation for thoracic surgery.

Authors:  Qiong Li; Peiying Li; Jianghui Xu; Huahua Gu; Qinyun Ma; Liewen Pang; Weimin Liang
Journal:  Exp Ther Med       Date:  2014-09-15       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.